Trials / Completed
CompletedNCT05174143
Personalized Antiplatelet Therapy in CAD Patients
Personalized Antiplatelet Therapy According to CYP2C19 Genotype in Coronary Artery Disease: A Real World Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15,000 (actual)
- Sponsor
- Xinjiang Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
This study is a prospective, no-randomized, single-center study performed on 15000 consecutive coronary artery patients from Dec. 2016 to Oct. 2021. All these patients were detected CYP2C19 genotype. The antiplatelet treatment was recorded according to the therapy actually adopted by the patients.
Conditions
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2021-06-01
- Completion
- 2021-10-01
- First posted
- 2021-12-30
- Last updated
- 2021-12-30
Source: ClinicalTrials.gov record NCT05174143. Inclusion in this directory is not an endorsement.